NCT06248762 PPI and Mindfulness App for Parents of Children with a NDD
| NCT ID | NCT06248762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Twente |
| Condition | Stress |
| Study Type | INTERVENTIONAL |
| Enrollment | 212 participants |
| Start Date | 2024-12-03 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 212 participants in total. It began in 2024-12-03 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An app based on positive psychology and mindfulness to support the mental well-being of parents of children with a Neurodevelopmental Disorder (NDD) was developed and will be evaluated on effectiveness.
Eligibility Criteria
Inclusion Criteria: 1. at least 18 years 2. parent of one or more children (\< 18 years) diagnosed with or suspected of a NDD 3. having access to internet 4. in possession of an e-mail address, 5. in possession of a smartphone or tablet 6. willing to use the digital intervention for a month, daily for approximately 15 minutes a day. Exclusion Criteria: 1. presence of severe anxiety symptoms 2. presence of moderately severe to severe depressive symptoms 3. being in treatment for mental health issues (the parent self)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06248762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06248762 currently recruiting?
Yes, NCT06248762 is actively recruiting participants. Contact the research team at k.j.m.tonis@utwente.nl for enrollment information.
Where is the NCT06248762 trial being conducted?
This trial is being conducted at Enschede, Netherlands.
Who is sponsoring the NCT06248762 clinical trial?
NCT06248762 is sponsored by University of Twente. The trial plans to enroll 212 participants.